Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/12
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > 25 or more peptide repeating units in known peptide chain structure
Description: Subject matter wherein a peptide chain has 25 or more peptide units in an uninterrupted chain.

Patents under this class:

Patent Number Title Of Patent Date Issued
7786082 Combinations of human proteins to enhance in vivo viability of stem cells and progenitor cells Aug. 31, 2010
7786081 Peptide composition Aug. 31, 2010
7786080 Mutein of a bone morphogenetic protein and use thereof Aug. 31, 2010
7786071 Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same Aug. 31, 2010
7785856 Acid alpha-glucosidase and fragments thereof Aug. 31, 2010
7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use Aug. 31, 2010
7785625 Lipophilic-coated microparticle containing a protein drug and formulation comprising same Aug. 31, 2010
7785582 Use of synovium and omentum for tissue engineering Aug. 31, 2010
7785580 Modified IL-4 mutein receptor antagonists Aug. 31, 2010
7781404 IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof Aug. 24, 2010
7781402 Methods and implantable devices for treating supraventricular arrhythmias Aug. 24, 2010
7781401 Glucagon-like peptide-2 analogs Aug. 24, 2010
7781215 Vertebrate embryonic pattern-inducing proteins, and uses related thereto Aug. 24, 2010
7781158 Method of separating collagen from the various animal tissues for producing collagen solution and product using the same Aug. 24, 2010
7780968 Clostridial toxin derivatives and methods for treating pain Aug. 24, 2010
7776826 Method for fostering bone formation and preservation Aug. 17, 2010
7776825 Mutant polypeptides of fibroblast growth factor 1 Aug. 17, 2010
7776824 NGAL for reduction and amelioration of ischemic and nephrotoxic injuries Aug. 17, 2010
7776823 Human cathelicidin antimicrobial peptides Aug. 17, 2010
7776822 Intrathecal and intratumoral superantigens to treat malignant disease Aug. 17, 2010
7772222 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same Aug. 10, 2010
7772185 Method for promoting axonal outgrowth in damaged nerves Aug. 10, 2010
7771931 Methods for diagnosing and treating diseases and conditions associated with protein kinase C.lamda. Aug. 10, 2010
7771755 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins Aug. 10, 2010
7771714 Medium comprising chicken leukemia inhibitory factor (LIF) Aug. 10, 2010
7767647 Method of the invention preparations of factor IXa Aug. 3, 2010
7767646 Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds Aug. 3, 2010
7767642 Therapeutic peptides for the treatment of metastatic cancer Aug. 3, 2010
7767641 Regulator of endothelial cell function and vessel remodeling Aug. 3, 2010
7767417 Prenyl-electrostatic switch, and methods of use Aug. 3, 2010
7763594 Compositions for the treatment of osteoarthritis and to nourish the synovial fluid Jul. 27, 2010
7763585 Methods for inhibiting tumor cell proliferation Jul. 27, 2010
7763441 Modulators of gluconeogenesis Jul. 27, 2010
7763257 Compositions comprising transforming growth factor (TGF)-.beta.1 and TGF-.beta.2 in admixture of proteins obtained from dairy products Jul. 27, 2010
7763242 Methods for treating myelodysplastic syndrome with a human interleukin-3-diphtheria toxin conjugate Jul. 27, 2010
7759310 Mineral collagen chelates and methods of making and using same Jul. 20, 2010
7759309 Use of polypeptides in treating tissue injury Jul. 20, 2010
7758894 Modified elapid venoms as stimulators of the immune reaction Jul. 20, 2010
7758862 Hepatocyte growth factor receptor splice variants and methods of using same Jul. 20, 2010
7758857 Stimulation of hematopoiesis by ex vivo activated immune cells Jul. 20, 2010
7758852 OX40R binding agents Jul. 20, 2010
7754689 Finger-1 peptide analogs of the TGF-.beta. superfamily Jul. 13, 2010
7754688 Methods of using retro-inverso peptides derived from interleukin-6 Jul. 13, 2010
7754687 Methods of inhibiting viral infection Jul. 13, 2010
7754686 Stabilized FGF formulations containing reducing agents Jul. 13, 2010
7754683 Bioactive peptide of bone morphogenetic protein-2 Jul. 13, 2010
7754220 Methods of inhibiting secretion of follicle-stimulating hormone and testosterone Jul. 13, 2010
7749965 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use Jul. 6, 2010
7749964 Methods and compositions for healing and repair of articular cartilage Jul. 6, 2010
7749963 Isolated recombinant vaccinia virus complement control protein (hrVCP) polypeptide Jul. 6, 2010

  Recently Added Patents
TRPM8 antagonists and their use in treatments
High surface area composition for use in the catalytic hydroconversion of a heavy hydrocarbon feedstock, a method making such composition and its use
Vehicle control system
Fused thiazole derivatives as kinase inhibitors
Multi-wired antenna for mobile apparatus
Semiconductor memory device, method of controlling read preamble signal thereof, and data transmission method
  Randomly Featured Patents
Tip-resistant sheet for standing articles
Compression sleeve puller with double thread engagement
Integrated-circuit chip with voltage divider
High-temperature storage battery
Coated lithium electrodes
Shingled magnetic recording (SMR) head with bent trailing shield and methods of production thereof
Dispenser for volatilizable substances
Media display unit
Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device